Huimin Yu

Shantou University — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

16h-index1.2kcitations51works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory Bowel Disease(7), Legume Nitrogen Fixing Symbiosis(4), Cancer Cells and Metastasis(3), Pharmaceutical Practices and Patient Outcomes(3), Immunotherapy and Immune Responses(3)

Publications51 total

Adult isolated coronary artery ectasia: clinical features and long-term outcomes
Frontiers in Cardiovascular Medicine·2026Open Access
144 Patient Perspectives on Artificial Intelligence Tools in Inflammatory Bowel Disease
The American Journal of Gastroenterology·2025
151 The Impact of Artificial Intelligence Upon IBD Patients' Decision Making in Disease Management
The American Journal of Gastroenterology·2025
131 Patient Utilization of Artificial Intelligence Tools for Symptom Management in Inflammatory Bowel Disease
The American Journal of Gastroenterology·2025
146 Patients’ Use of Artificial Intelligence Tools for Diet and Nutrition Advice in Inflammatory Bowel Disease
The American Journal of Gastroenterology·2025
Polysaccharide from Ziziphus jujuba fruit protects ulcerative colitis mice via IL-33/ST2 signal Axis
Journal of Functional Foods·2025· 1 citedOpen Access
Role of m6A methyltransferase METTL3 in keratoconus pathogenesis
Experimental Eye Research·2024
Data – Knowledge driven machine learning model for cancer pain medication decisions
International Journal of Medical Informatics·2024
Optimizing medication guidance support for patients with cancer pain: development and evaluation of a pharmaceutical care system for healthcare professionals
Supportive Care in Cancer·2024· 1 cited
Construction and application of medication reminder system: intelligent generation of universal medication schedule
BioData Mining·2024· 7 citedOpen Access
Research on Data – Knowledge-Driven Machine Learning Model for Drug Decision of Cancer Pain (Preprint)
2024Open Access
587 PARTIALLY DIFFERENTIATED ILEAL AND RECTAL HUMAN CFTRF508DEL ENTEROIDS SECRETE FLUID IN RESPONSE TO CAMP AND CGMP
Gastroenterology·2024
1239 PAIN IN INFLAMMATORY BOWEL DISEASE: A FUNCTION OF DISEASE ACTIVITY OR CENTRAL SENSITIZATION?
Gastroenterology·2024
PEACE: A Dataset of Pharmaceutical Care for Cancer Pain Analgesia Evaluation and Medication Decision
2024
Comparative proteomic analysis identifies proteins associated with arbuscular mycorrhizal symbiosis in Poncirus trifoliata
Frontiers in Plant Science·2023· 3 citedOpen Access
Corrigendum: Therapy by physician–pharmacist combination and economic returns for cancer pain management in China: a cost-effectiveness analysis
Frontiers in Pharmacology·2023Open Access
Antibody Kinetics after Three Doses of SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease
Medicina·2023Open Access
Therapy by physician–pharmacist combination and economic returns for cancer pain management in China: a cost-effectiveness analysis
Frontiers in Pharmacology·2023· 4 citedOpen Access
Plant lysin motif extracellular proteins are required for arbuscular mycorrhizal symbiosis
Proceedings of the National Academy of Sciences·2023· 26 citedOpen Access
Post-Marketing Safety Concerns with Upadacitinib: A Disproportionality Analysis of the FDA Adverse Event Reporting system
Expert Opinion on Drug Safety·2023· 12 cited
page 1 of 3Next →

Frequent Co-authors

Mark Donowitz(10), Jian Xiao(7), Florin M. Selaru(6), Jeremy Nathans(5), Ling Huang(5), Tyrus Vong(4), Shunyuan Xiao(4), Xikui Lu(4), Zixin Zhang(4), Hangxing Huang(4), Jingyang Li(4), Lu Zhang(4), Pavan Vemulakonda(4), Athanasios S. Naum(4), Lucas Miecho Heilbroner(4), Vinay Rao(4), Sumona Bhattacharya(4), Marie L. Borum(4), Amir Rattner(3), Philip M. Smallwood(3)